<DOC>
	<DOC>NCT00044707</DOC>
	<brief_summary>This is a randomized, single-blind, placebo-controlled, crossover study to examine the effect of pramlintide on the pharmacokinetics of an orally administered medication</brief_summary>
	<brief_title>Evaluation of an Orally Administered Medication When Taken in Conjunction With Pramlintide</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Pramlintide</mesh_term>
	<mesh_term>Islet Amyloid Polypeptide</mesh_term>
	<criteria>Type 2 diabetes mellitus treated with diet and/or oral agents HbA1c 6.511.0</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Diabetes Mellitus, Type 2</keyword>
</DOC>